Selected research
Market Structure
Global Organ Preservation Solutions Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Organ Preservation Solutions market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Organ Preservation Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Organ Preservation Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Organ Preservation Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Organ Preservation Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Organ Preservation Solutions include 21st Century Medicine, BioLife Solutions, Inc., BioTime, Inc., Bristol-Myers Squibb, Claris Lifesciences Limited, CryoLife, Inc., Dr. Franz Köhler Chemie, Lifeline Scientific and Teva Pharmaceutical Industries Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Organ Preservation Solutions market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Organ Preservation Solutions and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Organ Preservation Solutions revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Organ Preservation Solutions market size, projected growth trends, production technologies, key applications, and end-use industries.
Organ Preservation Solutions Segment by Company
21st Century Medicine
BioLife Solutions, Inc.
BioTime, Inc.
Bristol-Myers Squibb
Claris Lifesciences Limited
CryoLife, Inc.
Dr. Franz Köhler Chemie
Lifeline Scientific
Teva Pharmaceutical Industries Ltd.
ToleroTech, Inc
XVIVO Perfusion AB
Organ Preservation Solutions Segment by Type
Viaspan
Custodial
siRNA Transplant Solutions
Others
Organ Preservation Solutions Segment by Application
Hypothermic Perfusion Preservation (HPP)
Static Cold Storage (SCS)
Others
Organ Preservation Solutions Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Organ Preservation Solutions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Organ Preservation Solutions and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Organ Preservation Solutions.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Organ Preservation Solutions in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Organ Preservation Solutions industry.
Chapter 3: Detailed analysis of Organ Preservation Solutions companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Organ Preservation Solutionsrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Viaspan
- Custodial
- siRNA Transplant Solutions
- Others
Applications
- Hypothermic Perfusion Preservation (HPP)
- Static Cold Storage (SCS)
- Others
Companies covered
- 21st Century Medicine
- BioLife Solutions, Inc.
- BioTime, Inc.
- Bristol-Myers Squibb
- Claris Lifesciences Limited
- CryoLife, Inc.
- Dr. Franz Köhler Chemie
- Lifeline Scientific
- Teva Pharmaceutical Industries Ltd.
- ToleroTech, Inc
- XVIVO Perfusion AB
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Organ Preservation Solutions Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Viaspan
- 1.2.3 Custodial
- 1.2.4 siRNA Transplant Solutions
- 1.2.5 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Organ Preservation Solutions Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hypothermic Perfusion Preservation (HPP)
- 1.3.3 Static Cold Storage (SCS)
- 1.3.4 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Organ Preservation Solutions Growth Trends by Region
- 1.5.1 Global Organ Preservation Solutions Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Organ Preservation Solutions Market Size by Region (2021-2026)
- 1.5.3 Organ Preservation Solutions Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Organ Preservation Solutions Market Dynamics
- 2.1 Organ Preservation Solutions Industry Trends
- 2.2 Organ Preservation Solutions Industry Drivers
- 2.3 Organ Preservation Solutions Industry Opportunities and Challenges
- 2.4 Organ Preservation Solutions Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Organ Preservation Solutions Revenue by Company (2021-2026)
- 3.2 Global Organ Preservation Solutions Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Organ Preservation Solutions Key Company Head office and Area Served
- 3.4 Global Organ Preservation Solutions Company, Product Type & Application
- 3.5 Global Organ Preservation Solutions Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Organ Preservation Solutions Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Organ Preservation Solutions Players Market Share by Revenue in 2025
- 3.6.3 2025 Organ Preservation Solutions Tier 1, Tier 2, and Tier 3
4 Organ Preservation Solutions Market by Type
- 4.1 Global Organ Preservation Solutions Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Organ Preservation Solutions Market Size by Type (2021-2032)
- 4.3 Global Organ Preservation Solutions Market Size Share by Type (2021-2032)
5 Organ Preservation Solutions Market by Application
- 5.1 Global Organ Preservation Solutions Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Organ Preservation Solutions Market Size by Application (2021-2032)
- 5.3 Global Organ Preservation Solutions Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 21st Century Medicine
- 6.1.1 21st Century Medicine Company Information
- 6.1.2 21st Century Medicine Business Overview
- 6.1.3 21st Century Medicine Organ Preservation Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 21st Century Medicine Organ Preservation Solutions Product Portfolio
- 6.1.5 21st Century Medicine Recent Developments
- 6.2 BioLife Solutions, Inc.
- 6.2.1 BioLife Solutions, Inc. Company Information
- 6.2.2 BioLife Solutions, Inc. Business Overview
- 6.2.3 BioLife Solutions, Inc. Organ Preservation Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 BioLife Solutions, Inc. Organ Preservation Solutions Product Portfolio
- 6.2.5 BioLife Solutions, Inc. Recent Developments
- 6.3 BioTime, Inc.
- 6.3.1 BioTime, Inc. Company Information
- 6.3.2 BioTime, Inc. Business Overview
- 6.3.3 BioTime, Inc. Organ Preservation Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 BioTime, Inc. Organ Preservation Solutions Product Portfolio
- 6.3.5 BioTime, Inc. Recent Developments
- 6.4 Bristol-Myers Squibb
- 6.4.1 Bristol-Myers Squibb Company Information
- 6.4.2 Bristol-Myers Squibb Business Overview
- 6.4.3 Bristol-Myers Squibb Organ Preservation Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Bristol-Myers Squibb Organ Preservation Solutions Product Portfolio
- 6.4.5 Bristol-Myers Squibb Recent Developments
- 6.5 Claris Lifesciences Limited
- 6.5.1 Claris Lifesciences Limited Company Information
- 6.5.2 Claris Lifesciences Limited Business Overview
- 6.5.3 Claris Lifesciences Limited Organ Preservation Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Claris Lifesciences Limited Organ Preservation Solutions Product Portfolio
- 6.5.5 Claris Lifesciences Limited Recent Developments
- 6.6 CryoLife, Inc.
- 6.6.1 CryoLife, Inc. Company Information
- 6.6.2 CryoLife, Inc. Business Overview
- 6.6.3 CryoLife, Inc. Organ Preservation Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 CryoLife, Inc. Organ Preservation Solutions Product Portfolio
- 6.6.5 CryoLife, Inc. Recent Developments
- 6.7 Dr. Franz Köhler Chemie
- 6.7.1 Dr. Franz Köhler Chemie Company Information
- 6.7.2 Dr. Franz Köhler Chemie Business Overview
- 6.7.3 Dr. Franz Köhler Chemie Organ Preservation Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Dr. Franz Köhler Chemie Organ Preservation Solutions Product Portfolio
- 6.7.5 Dr. Franz Köhler Chemie Recent Developments
- 6.8 Lifeline Scientific
- 6.8.1 Lifeline Scientific Company Information
- 6.8.2 Lifeline Scientific Business Overview
- 6.8.3 Lifeline Scientific Organ Preservation Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Lifeline Scientific Organ Preservation Solutions Product Portfolio
- 6.8.5 Lifeline Scientific Recent Developments
- 6.9 Teva Pharmaceutical Industries Ltd.
- 6.9.1 Teva Pharmaceutical Industries Ltd. Company Information
- 6.9.2 Teva Pharmaceutical Industries Ltd. Business Overview
- 6.9.3 Teva Pharmaceutical Industries Ltd. Organ Preservation Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Teva Pharmaceutical Industries Ltd. Organ Preservation Solutions Product Portfolio
- 6.9.5 Teva Pharmaceutical Industries Ltd. Recent Developments
- 6.10 ToleroTech, Inc
- 6.10.1 ToleroTech, Inc Company Information
- 6.10.2 ToleroTech, Inc Business Overview
- 6.10.3 ToleroTech, Inc Organ Preservation Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 ToleroTech, Inc Organ Preservation Solutions Product Portfolio
- 6.10.5 ToleroTech, Inc Recent Developments
- 6.11 XVIVO Perfusion AB
- 6.11.1 XVIVO Perfusion AB Company Information
- 6.11.2 XVIVO Perfusion AB Business Overview
- 6.11.3 XVIVO Perfusion AB Organ Preservation Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 XVIVO Perfusion AB Organ Preservation Solutions Product Portfolio
- 6.11.5 XVIVO Perfusion AB Recent Developments
7 North America
- 7.1 North America Organ Preservation Solutions Market Size (2021-2032)
- 7.2 North America Organ Preservation Solutions Market Size by Type
- 7.2.1 North America Organ Preservation Solutions Market Size by Type (2021-2026)
- 7.2.2 North America Organ Preservation Solutions Market Size by Type (2027-2032)
- 7.2.3 North America Organ Preservation Solutions Market Share by Type (2021-2032)
- 7.3 North America Organ Preservation Solutions Market Size by Application
- 7.3.1 North America Organ Preservation Solutions Market Size by Application (2021-2026)
- 7.3.2 North America Organ Preservation Solutions Market Size by Application (2027-2032)
- 7.3.3 North America Organ Preservation Solutions Market Share by Application (2021-2032)
- 7.4 North America Organ Preservation Solutions Market Size by Country
- 7.4.1 North America Organ Preservation Solutions Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Organ Preservation Solutions Market Size by Country (2021-2026)
- 7.4.3 North America Organ Preservation Solutions Market Size by Country (2027-2032)
- 7.4.4 North America Organ Preservation Solutions Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Organ Preservation Solutions Market Size (2021-2032)
- 8.2 Europe Organ Preservation Solutions Market Size by Type
- 8.2.1 Europe Organ Preservation Solutions Market Size by Type (2021-2026)
- 8.2.2 Europe Organ Preservation Solutions Market Size by Type (2027-2032)
- 8.2.3 Europe Organ Preservation Solutions Market Share by Type (2021-2032)
- 8.3 Europe Organ Preservation Solutions Market Size by Application
- 8.3.1 Europe Organ Preservation Solutions Market Size by Application (2021-2026)
- 8.3.2 Europe Organ Preservation Solutions Market Size by Application (2027-2032)
- 8.3.3 Europe Organ Preservation Solutions Market Share by Application (2021-2032)
- 8.4 Europe Organ Preservation Solutions Market Size by Country
- 8.4.1 Europe Organ Preservation Solutions Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Organ Preservation Solutions Market Size by Country (2021-2026)
- 8.4.3 Europe Organ Preservation Solutions Market Size by Country (2027-2032)
- 8.4.4 Europe Organ Preservation Solutions Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Organ Preservation Solutions Market Size (2021-2032)
- 9.2 China Organ Preservation Solutions Market Size by Type
- 9.2.1 China Organ Preservation Solutions Market Size by Type (2021-2026)
- 9.2.2 China Organ Preservation Solutions Market Size by Type (2027-2032)
- 9.2.3 China Organ Preservation Solutions Market Share by Type (2021-2032)
- 9.3 China Organ Preservation Solutions Market Size by Application
- 9.3.1 China Organ Preservation Solutions Market Size by Application (2021-2026)
- 9.3.2 China Organ Preservation Solutions Market Size by Application (2027-2032)
- 9.3.3 China Organ Preservation Solutions Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Organ Preservation Solutions Market Size (2021-2032)
- 10.2 Asia Organ Preservation Solutions Market Size by Type
- 10.2.1 Asia Organ Preservation Solutions Market Size by Type (2021-2026)
- 10.2.2 Asia Organ Preservation Solutions Market Size by Type (2027-2032)
- 10.2.3 Asia Organ Preservation Solutions Market Share by Type (2021-2032)
- 10.3 Asia Organ Preservation Solutions Market Size by Application
- 10.3.1 Asia Organ Preservation Solutions Market Size by Application (2021-2026)
- 10.3.2 Asia Organ Preservation Solutions Market Size by Application (2027-2032)
- 10.3.3 Asia Organ Preservation Solutions Market Share by Application (2021-2032)
- 10.4 Asia Organ Preservation Solutions Market Size by Country
- 10.4.1 Asia Organ Preservation Solutions Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Organ Preservation Solutions Market Size by Country (2021-2026)
- 10.4.3 Asia Organ Preservation Solutions Market Size by Country (2027-2032)
- 10.4.4 Asia Organ Preservation Solutions Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Organ Preservation Solutions Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Organ Preservation Solutions Market Size by Type
- 11.2.1 South America, Middle East & Africa Organ Preservation Solutions Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Organ Preservation Solutions Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Organ Preservation Solutions Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Organ Preservation Solutions Market Size by Application
- 11.3.1 South America, Middle East & Africa Organ Preservation Solutions Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Organ Preservation Solutions Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Organ Preservation Solutions Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Organ Preservation Solutions Market Size by Country
- 11.4.1 South America, Middle East & Africa Organ Preservation Solutions Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Organ Preservation Solutions Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Organ Preservation Solutions Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Organ Preservation Solutions Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst